Skip to main content
. 2015 Feb 26;308(9):G785–G793. doi: 10.1152/ajpgi.00458.2014

Fig. 7.

Fig. 7.

Model for indomethacin-induced inhibition of small intestinal smooth muscle contractility. Indomethacin causes mucosal damage, which initiates a feedback loop involving inflammatory damage to smooth muscle layers, which decreases intestinal smooth muscle contractility. The decreased intestinal contractility enhances the bacterial overgrowth and translocation initiated by the damaged mucosa.